EFHD2 Antikörper (N-Term)
-
- Target Alle EFHD2 Antikörper anzeigen
- EFHD2 (EF-Hand Domain Family, Member D2 (EFHD2))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EFHD2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- EFHD2 antibody was raised against the N terminal of EFHD2
- Aufreinigung
- Affinity purified
- Immunogen
- EFHD2 antibody was raised using the N terminal of EFHD2 corresponding to a region with amino acids MGTPGEGLGRCSHALIRGVPESLASGEGAGAGLPALDLAKAQREHGVLGG
- Top Product
- Discover our top product EFHD2 Primärantikörper
-
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
EFHD2 Blocking Peptide, catalog no. 33R-6081, is also available for use as a blocking control in assays to test for specificity of this EFHD2 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EFHD2 antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- EFHD2 (EF-Hand Domain Family, Member D2 (EFHD2))
- Andere Bezeichnung
- EFHD2 (EFHD2 Produkte)
- Hintergrund
- EFHD2 may regulate B-cell receptor (BCR)-induced immature and primary B-cell apoptosis. It plays a role as negative regulator of the canonical NF-kappa-B-activating branch. EFHD2 controls spontaneous apoptosis through the regulation of BCL2L1 abundance.
- Molekulargewicht
- 26 kDa (MW of target protein)
-